• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心肌空化增强疗法诱导病变的成熟

Maturation of Lesions Induced by Myocardial Cavitation-Enabled Therapy.

作者信息

Lu Xiaofang, Miller Douglas L, Dou Chunyan, Zhu Yiying I, Fabiilli Mario L, Owens Gabe E, Kripfgans Oliver D

机构信息

University of Michigan Health System, Ann Arbor, Michigan, USA.

University of Michigan Health System, Ann Arbor, Michigan, USA.

出版信息

Ultrasound Med Biol. 2016 Jul;42(7):1541-50. doi: 10.1016/j.ultrasmedbio.2016.02.006. Epub 2016 Apr 14.

DOI:10.1016/j.ultrasmedbio.2016.02.006
PMID:27087693
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4899230/
Abstract

Myocardial contrast echocardiography at enhanced therapeutic parameters may be a novel means of tissue reduction therapy, as for hypertrophic cardiomyopathy. Dahl/SS rats were anesthetized and treated with high-amplitude pulsed ultrasound guided by 10-MHz ultrasound images. Contrast microbubbles were infused via the tail vein during intermittent pulse-burst exposure at 4 MPa. A sham group, a low-impact group (group A, 5 cycle pulses with Gaussian modulation and 1:4 trigger for 5 min) and a high-impact group (group B, 10 cycle pulses with 4-ms square modulation and 1:8 trigger for 10 min) were tested. The higher exposure used in group B yielded more substantial injury than the lower exposure in group A. Treated rats in both groups A and B had significant increases in wall thickness measured by echocardiography the next day, which returned to normal by the end of 6 wk. Six weeks after ultrasound exposure, heart tissue samples exhibited tissue fibrosis in Masson's trichrome stained histology. Maturation of lesions involved fibrosis replacement, preserving structural tissue integrity. This study indicates that myocardial injury noted previously progresses into permanent loss of myocardial tissue that may be sufficient for possible hypertrophic cardiomyopathy therapy. More research is needed to define the treatment parameters required for symptomatic relief for hypertrophic cardiomyopathy.

摘要

对于肥厚型心肌病,在增强治疗参数下的心肌对比超声心动图可能是一种新型的组织消减治疗方法。将 Dahl/SS 大鼠麻醉,在 10 兆赫兹超声图像引导下用高振幅脉冲超声进行治疗。在 4 兆帕的间歇脉冲群暴露期间,通过尾静脉注入造影微泡。测试了假手术组、低强度组(A 组,5 个周期脉冲,高斯调制,1:4 触发,持续 5 分钟)和高强度组(B 组,10 个周期脉冲,4 毫秒方波调制,1:8 触发,持续 10 分钟)。B 组使用的较高暴露比 A 组的较低暴露造成了更严重的损伤。A 组和 B 组的治疗大鼠在第二天通过超声心动图测量的壁厚均显著增加,到 6 周结束时恢复正常。超声暴露 6 周后,心脏组织样本在 Masson 三色染色组织学中显示出组织纤维化。病变的成熟涉及纤维化替代,保持组织结构完整性。本研究表明,先前观察到的心肌损伤进展为心肌组织的永久性丧失,这可能足以用于可能的肥厚型心肌病治疗。需要更多研究来确定肥厚型心肌病症状缓解所需的治疗参数。

相似文献

1
Maturation of Lesions Induced by Myocardial Cavitation-Enabled Therapy.心肌空化增强疗法诱导病变的成熟
Ultrasound Med Biol. 2016 Jul;42(7):1541-50. doi: 10.1016/j.ultrasmedbio.2016.02.006. Epub 2016 Apr 14.
2
Ultrasonic Cavitation-Enabled Treatment for Therapy of Hypertrophic Cardiomyopathy: Proof of Principle.超声空化辅助治疗肥厚型心肌病:原理验证
Ultrasound Med Biol. 2018 Jul;44(7):1439-1450. doi: 10.1016/j.ultrasmedbio.2018.03.010. Epub 2018 Apr 19.
3
Optimization of ultrasound parameters of myocardial cavitation microlesions for therapeutic application.用于治疗应用的心肌空化微损伤超声参数的优化。
Ultrasound Med Biol. 2014 Jun;40(6):1228-36. doi: 10.1016/j.ultrasmedbio.2014.01.001. Epub 2014 Mar 6.
4
Hemocoagulase Combined with Microbubble-Enhanced Ultrasound Cavitation for Augmented Ablation of Microvasculature in Rabbit VX2 Liver Tumors.血凝酶联合微泡增强超声空化用于增强兔VX2肝肿瘤微血管消融
Ultrasound Med Biol. 2017 Aug;43(8):1658-1670. doi: 10.1016/j.ultrasmedbio.2017.03.013. Epub 2017 May 22.
5
Influence of contrast agent dose and ultrasound exposure on cardiomyocyte injury induced by myocardial contrast echocardiography in rats.造影剂剂量和超声暴露对大鼠心肌对比超声心动图诱导的心肌细胞损伤的影响。
Radiology. 2005 Oct;237(1):137-43. doi: 10.1148/radiol.2371041467.
6
[Myocardial contrast echocardiography guided alcohol septal ablation in hypertrophic obstructive cardiomyopathy with a new echocardiographic contrast agent].[新型超声心动图造影剂引导下的心肌对比超声心动图在肥厚型梗阻性心肌病酒精室间隔消融术中的应用]
Dtsch Med Wochenschr. 2012 Oct;137(41):2093-6. doi: 10.1055/s-0032-1305229. Epub 2012 Oct 2.
7
Use of Theranostic Strategies in Myocardial Cavitation-Enabled Therapy.治疗诊断策略在心肌空化治疗中的应用。
Ultrasound Med Biol. 2015 Jul;41(7):1865-75. doi: 10.1016/j.ultrasmedbio.2015.03.019. Epub 2015 Apr 15.
8
Timing of high-intensity pulses for myocardial cavitation-enabled therapy.用于心肌空化介导治疗的高强度脉冲的定时
J Ther Ultrasound. 2014 Oct 2;2:20. doi: 10.1186/2050-5736-2-20. eCollection 2014.
9
Characterization of macrolesions induced by myocardial cavitation-enabled therapy.心肌空化效应介导治疗所诱导的大损伤的特征分析
IEEE Trans Biomed Eng. 2015 Feb;62(2):717-27. doi: 10.1109/TBME.2014.2364263. Epub 2014 Oct 22.
10
Enhancement and Passive Acoustic Mapping of Cavitation from Fluorescently Tagged Magnetic Resonance-Visible Magnetic Microbubbles In Vivo.体内荧光标记的磁共振可见磁性微泡空化的增强与被动声学映射
Ultrasound Med Biol. 2016 Dec;42(12):3022-3036. doi: 10.1016/j.ultrasmedbio.2016.08.002. Epub 2016 Sep 22.

引用本文的文献

1
Early assessment and treatment of ventricular remodeling in vivo via a targeted ultrasonic molecular probe loaded with oxygen and cholecystokinin.通过负载氧气和胆囊收缩素的靶向超声分子探针在体内对心室重构进行早期评估和治疗。
J Nanobiotechnology. 2025 Feb 12;23(1):104. doi: 10.1186/s12951-025-03183-7.
2
Overview of Therapeutic Ultrasound Applications and Safety Considerations: 2024 Update.治疗性超声应用概述与安全考量:2024年更新
J Ultrasound Med. 2025 Mar;44(3):381-433. doi: 10.1002/jum.16611. Epub 2024 Nov 11.
3
Ultrasonic Cavitation-Enabled Treatment for Therapy of Hypertrophic Cardiomyopathy: Proof of Principle.

本文引用的文献

1
Quantitative assessment of damage during MCET: a parametric study in a rodent model.微通道增强超声靶向治疗(MCET)期间损伤的定量评估:啮齿动物模型的参数研究
J Ther Ultrasound. 2015 Oct 16;3:18. doi: 10.1186/s40349-015-0039-2. eCollection 2015.
2
Use of Theranostic Strategies in Myocardial Cavitation-Enabled Therapy.治疗诊断策略在心肌空化治疗中的应用。
Ultrasound Med Biol. 2015 Jul;41(7):1865-75. doi: 10.1016/j.ultrasmedbio.2015.03.019. Epub 2015 Apr 15.
3
New perspectives on the prevalence of hypertrophic cardiomyopathy.肥厚型心肌病患病率的新视角。
超声空化辅助治疗肥厚型心肌病:原理验证
Ultrasound Med Biol. 2018 Jul;44(7):1439-1450. doi: 10.1016/j.ultrasmedbio.2018.03.010. Epub 2018 Apr 19.
4
Multiple ultrasound cavitation-enabled treatments for myocardial reduction.多种超声空化辅助治疗心肌减容术
J Ther Ultrasound. 2017 Nov 9;5:29. doi: 10.1186/s40349-017-0107-x. eCollection 2017.
J Am Coll Cardiol. 2015 Mar 31;65(12):1249-1254. doi: 10.1016/j.jacc.2015.01.019.
4
Characterization of macrolesions induced by myocardial cavitation-enabled therapy.心肌空化效应介导治疗所诱导的大损伤的特征分析
IEEE Trans Biomed Eng. 2015 Feb;62(2):717-27. doi: 10.1109/TBME.2014.2364263. Epub 2014 Oct 22.
5
Timing of high-intensity pulses for myocardial cavitation-enabled therapy.用于心肌空化介导治疗的高强度脉冲的定时
J Ther Ultrasound. 2014 Oct 2;2:20. doi: 10.1186/2050-5736-2-20. eCollection 2014.
6
Optimization of ultrasound parameters of myocardial cavitation microlesions for therapeutic application.用于治疗应用的心肌空化微损伤超声参数的优化。
Ultrasound Med Biol. 2014 Jun;40(6):1228-36. doi: 10.1016/j.ultrasmedbio.2014.01.001. Epub 2014 Mar 6.
7
Cardiovascular drug delivery with ultrasound and microbubbles.超声和微泡介导的心血管药物递送
Adv Drug Deliv Rev. 2014 Jun;72:110-26. doi: 10.1016/j.addr.2014.01.012. Epub 2014 Feb 11.
8
An assessment of regression of left ventricular hypertrophy following alcohol ablation of the interventricular septum in patients with hypertrophic cardiomyopathy with left ventricular outflow tract obstruction.评估酒精消融肥厚型梗阻性心肌病患者室间隔肥厚后左心室肥厚的消退情况。
Kardiol Pol. 2012;70(8):782-8.
9
Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives.肥厚型心肌病 20 年后的遗传学:临床观点。
J Am Coll Cardiol. 2012 Aug 21;60(8):705-15. doi: 10.1016/j.jacc.2012.02.068. Epub 2012 Jul 11.
10
2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.2011年美国心脏病学会基金会/美国心脏协会肥厚型心肌病诊断与治疗指南:执行摘要:美国心脏病学会基金会/美国心脏协会实践指南工作组报告
Circulation. 2011 Dec 13;124(24):2761-96. doi: 10.1161/CIR.0b013e318223e230. Epub 2011 Nov 8.